Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates accelerated wound healing in radiation-induced skin injury models, indicating microneedle-mediated ferroptosis inhibition enhances tissue repair.
Radiation-induced skin injury (RSI) presents a significant challenge in wound care due to its complex pathophysiology, which includes increased oxidative stress, impaired angiogenesis, and delayed re-epithelialization. Transcriptomic analysis reveals significant alterations in genes associated with the ferroptosis pathway following radiation exposure. In this study, we introduce microneedles composed of silk fibroin hydrogel loaded with deferoxamine (SF+MNs+DFO) to inhibit ferroptosis. SF+MNs+DFO exhibits optimal mechanical properties and drug release kinetics. Histopathological analysis shows reduced inflammation, oxidative stress, and collagen deposition in RSI treated with SF+MNs+DFO, leading to accelerated tissue regeneration and decreased scarring. Molecular biology studies indicate that SF+MNs+DFO inhibits ferroptosis by reducing the concentration of free Fe 2+ in the body, thereby decreasing the generation of reactive oxygen species (ROS) and lipid peroxidation. Immunofluorescence studies further confirm the increased neovascularization and reduced fibrosis in SF+MNs+DFO-treated RSI, indicating enhanced tissue repair. SF+MNs+DFO not only inhibits ferroptosis but also promotes angiogenesis and tissue regeneration, offering a promising therapeutic strategy for RSI. In conclusion, DFO-loaded SF hydrogel microneedles provide precise drug delivery, iron chelation, and improved wound healing, demonstrating an effective approach for treating RSI.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: